1037 related articles for article (PubMed ID: 8705854)
1. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.
Scheuner D; Eckman C; Jensen M; Song X; Citron M; Suzuki N; Bird TD; Hardy J; Hutton M; Kukull W; Larson E; Levy-Lahad E; Viitanen M; Peskind E; Poorkaj P; Schellenberg G; Tanzi R; Wasco W; Lannfelt L; Selkoe D; Younkin S
Nat Med; 1996 Aug; 2(8):864-70. PubMed ID: 8705854
[TBL] [Abstract][Full Text] [Related]
2. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
3. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.
Citron M; Westaway D; Xia W; Carlson G; Diehl T; Levesque G; Johnson-Wood K; Lee M; Seubert P; Davis A; Kholodenko D; Motter R; Sherrington R; Perry B; Yao H; Strome R; Lieberburg I; Rommens J; Kim S; Schenk D; Fraser P; St George Hyslop P; Selkoe DJ
Nat Med; 1997 Jan; 3(1):67-72. PubMed ID: 8986743
[TBL] [Abstract][Full Text] [Related]
4. [The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and A beta 1-42 (43)].
Younkin SG
Rinsho Shinkeigaku; 1997 Dec; 37(12):1099. PubMed ID: 9577655
[No Abstract] [Full Text] [Related]
5. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
[TBL] [Abstract][Full Text] [Related]
6. Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease.
Ancolio K; Marambaud P; Dauch P; Checler F
J Neurochem; 1997 Dec; 69(6):2494-9. PubMed ID: 9375682
[TBL] [Abstract][Full Text] [Related]
7. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.
Borchelt DR; Thinakaran G; Eckman CB; Lee MK; Davenport F; Ratovitsky T; Prada CM; Kim G; Seekins S; Yager D; Slunt HH; Wang R; Seeger M; Levey AI; Gandy SE; Copeland NG; Jenkins NA; Price DL; Younkin SG; Sisodia SS
Neuron; 1996 Nov; 17(5):1005-13. PubMed ID: 8938131
[TBL] [Abstract][Full Text] [Related]
8. Abeta42, presenilins, and Alzheimer's disease.
Iwatsubo T
Neurobiol Aging; 1998; 19(1 Suppl):S11-3. PubMed ID: 9562460
[TBL] [Abstract][Full Text] [Related]
9. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
Walker ES; Martinez M; Brunkan AL; Goate A
J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
[TBL] [Abstract][Full Text] [Related]
10. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
11. Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases.
Mastrangelo P; Mathews PM; Chishti MA; Schmidt SD; Gu Y; Yang J; Mazzella MJ; Coomaraswamy J; Horne P; Strome B; Pelly H; Levesque G; Ebeling C; Jiang Y; Nixon RA; Rozmahel R; Fraser PE; St George-Hyslop P; Carlson GA; Westaway D
Proc Natl Acad Sci U S A; 2005 Jun; 102(25):8972-7. PubMed ID: 15951428
[TBL] [Abstract][Full Text] [Related]
12. A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques.
Steiner H; Revesz T; Neumann M; Romig H; Grim MG; Pesold B; Kretzschmar HA; Hardy J; Holton JL; Baumeister R; Houlden H; Haass C
J Biol Chem; 2001 Mar; 276(10):7233-9. PubMed ID: 11084029
[TBL] [Abstract][Full Text] [Related]
13. [Molecular genetics of Alzheimer's disease--presenilin and other genes].
Tabira T
Rinsho Shinkeigaku; 1997 Dec; 37(12):1095-6. PubMed ID: 9577654
[TBL] [Abstract][Full Text] [Related]
14. Presenilin-1 mutations associated with familial Alzheimer's disease do not disrupt protein transport from the endoplasmic reticulum to the Golgi apparatus.
Tan Y; Hong J; Doan T; McConlogue L; Maltese WA
Biochim Biophys Acta; 1998 Jul; 1407(1):69-78. PubMed ID: 9639678
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease.
Murayama O; Tomita T; Nihonmatsu N; Murayama M; Sun X; Honda T; Iwatsubo T; Takashima A
Neurosci Lett; 1999 Apr; 265(1):61-3. PubMed ID: 10327206
[TBL] [Abstract][Full Text] [Related]
16. [Molecular cell biology of presenilins].
Tomita T; Iwatsubo T
Nihon Yakurigaku Zasshi; 1999 Dec; 114(6):337-46. PubMed ID: 10672594
[TBL] [Abstract][Full Text] [Related]
17. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
[TBL] [Abstract][Full Text] [Related]
18. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.
Borchelt DR; Ratovitski T; van Lare J; Lee MK; Gonzales V; Jenkins NA; Copeland NG; Price DL; Sisodia SS
Neuron; 1997 Oct; 19(4):939-45. PubMed ID: 9354339
[TBL] [Abstract][Full Text] [Related]
19. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
20. Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites.
Sudoh S; Kawamura Y; Sato S; Wang R; Saido TC; Oyama F; Sakaki Y; Komano H; Yanagisawa K
J Neurochem; 1998 Oct; 71(4):1535-43. PubMed ID: 9751187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
